StonvexLoading…
StonvexStonvexStonvexCore line items from PUK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.49B | $10.74B | $9.74B | $8.98B |
Operating Income | $3.31B | $3.13B | $2.89B | $2.72B |
Net Income | $4.12B | $2.42B | $1.71B | $-997.00M |
EPS (Diluted) | $1.53 | $0.84 | $0.62 | $-0.37 |
Total Assets | $212.19B | $181.88B | $174.07B | $160.25B |
Total Liabilities | $190.84B | $163.20B | $156.08B | $143.35B |
Cash & Equivalents | $7.71B | $5.77B | $4.75B | $5.51B |
Free Cash Flow OCF − CapEx | $2.35B | $3.51B | $788.00M | $1.04B |
Shares Outstanding | 2.55B | 2.66B | 2.75B | 2.75B |